124 studies found for:    Open Studies | "Neuroblastoma"
Show Display Options
Rank Status Study
21 Recruiting Therapy for Children With Advanced Stage Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin
22 Unknown  A Pilot Study on ALK Gene Mutations in Neuroblastoma
Condition: Neuroblastoma
23 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
24 Unknown  131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
25 Unknown  Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty
Condition: Neuroblastoma
26 Recruiting Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
Conditions: Neuroblastoma;   Bone Marrow, Sympathetic Nervous System
Intervention: Drug: cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
27 Not yet recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Condition: Neuroblastoma
Interventions: Drug: Ch14.18;   Biological: NK Cells;   Drug: Lenalidomide
28 Recruiting Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Conditions: Neuroblastoma;   Ewings Sarcoma;   Osteogenic Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma
Intervention: Biological: Autologous dendritic cell vaccine with adjuvant
29 Recruiting Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Sorafenib;   Drug: Cyclophosphamide;   Drug: Topotecan
30 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
31 Recruiting 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Condition: Neuroblastoma
Interventions: Radiation: 124I-MIBG (no-carrier added);   Radiation: 124I-MIBG (carrier added)
32 Not yet recruiting Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Conditions: Neuroblastoma;   Neoplasm, Residual;   Effects of Immunotherapy
Intervention: Drug: Dinutuximab. Immunotherapy
33 Recruiting MIBG for Refractory Neuroblastoma and Pheochromocytoma
Conditions: Relapsed Neuroblastoma;   Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131I-MIBG);   Drug: Potassium iodide solution;   Drug: G-CSF;   Procedure: hematopoietic stem cell infusion
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: Fludarabine;   Genetic: GINAKIT Cells
35 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Condition: Neuroblastoma
Intervention: Device: FLT-PET
36 Unknown  131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
37 Recruiting Parental Decision-Making for Children With Relapsed Neuroblastoma
Condition: Relapsed Neuroblastoma
38 Unknown  Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Busulfan - Fludarabine - TBI
39 Recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Radiation: iobenguane I 131
40 Recruiting Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib;   Drug: Rapamycin;   Drug: Irinotecan;   Drug: Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years